These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35377935)

  • 1. Reversal Agents in Sedation and Anesthesia Practice for Dentistry.
    Wong M
    Anesth Prog; 2022 Apr; 69(1):49-58. PubMed ID: 35377935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromuscular Blockade and Reversal Agent Practice Variability in the US Inpatient Surgical Settings.
    Bash LD; Turzhitsky V; Black W; Urman RD
    Adv Ther; 2021 Sep; 38(9):4736-4755. PubMed ID: 34319550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.
    Hristovska AM; Duch P; Allingstrup M; Afshari A
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012763. PubMed ID: 28806470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment.
    Chambers D; Paulden M; Paton F; Heirs M; Duffy S; Craig D; Hunter J; Wilson J; Sculpher M; Woolacott N
    Health Technol Assess; 2010 Jul; 14(39):1-211. PubMed ID: 20688009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sugammadex for reversal of neuromuscular blockade in pediatric patients: Results from a phase IV randomized study.
    Voss T; Wang A; DeAngelis M; Speek M; Saldien V; Hammer GB; Wrishko R; Herring WJ
    Paediatr Anaesth; 2022 Mar; 32(3):436-445. PubMed ID: 34878707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromuscular Blockade and Reversal Practice Variability in the Outpatient Setting: Insights From US Utilization Patterns.
    Bash LD; Black W; Turzhitsky V; Urman RD
    Anesth Analg; 2021 Dec; 133(6):1437-1450. PubMed ID: 34784330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Impact of Sugammadex in the Reversal of Neuromuscular Blockade.
    Goodner JA; Likar EJ; Hoff AL; Quedado JM; Kohli A; Ellison P
    Cureus; 2021 Jun; 13(6):e15413. PubMed ID: 34249560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of neuromuscular blockade reversal on bispectral index and frontal electromyogram during steady-state desflurane anesthesia: a randomized trial.
    Kim D; Ahn JH; Jung H; Choi KY; Jeong JS
    Sci Rep; 2019 Jul; 9(1):10486. PubMed ID: 31324862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sugammadex or neostigmine neuromuscular block reversal on bispectral index monitoring of propofol/remifentanil anaesthesia.
    Dahaba AA; Bornemann H; Hopfgartner E; Ohran M; Kocher K; Liebmann M; Wilfinger G; Metzler H
    Br J Anaesth; 2012 Apr; 108(4):602-6. PubMed ID: 22315331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
    Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
    Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of residual neuromuscular block and postoperative respiratory complications in patients reversed with neostigmine versus sugammadex.
    Martinez-Ubieto J; Ortega-Lucea S; Pascual-Bellosta A; Arazo-Iglesias I; Gil-Bona J; Jimenez-Bernardó T; Muñoz-Rodriguez L
    Minerva Anestesiol; 2016 Jul; 82(7):735-42. PubMed ID: 26472231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case series of 331 cases of sugammadex compared to neostigmine in patients under 2 years of age.
    Franz AM; Chiem J; Martin LD; Rampersad S; Phillips J; Grigg EB
    Paediatr Anaesth; 2019 Jun; 29(6):591-596. PubMed ID: 30934160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sugammadex versus neostigmine for routine reversal of rocuronium block in adult patients: A cost analysis.
    Hurford WE; Welge JA; Eckman MH
    J Clin Anesth; 2020 Dec; 67():110027. PubMed ID: 32980763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory muscle activity after spontaneous, neostigmine- or sugammadex-enhanced recovery of neuromuscular blockade: a double blind prospective randomized controlled trial.
    Schepens T; Janssens K; Maes S; Wildemeersch D; Vellinga J; Jorens PG; Saldien V
    BMC Anesthesiol; 2019 Oct; 19(1):187. PubMed ID: 31629404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery of early postoperative muscle strength after deep neuromuscular block by means of ultrasonography with comparison of neostigmine versus sugammadex as reversal drugs: study protocol for a randomised controlled trial.
    Wang X; Li Y; Huang C; Xiong W; Zhou Q; Niu L; Xiao Y
    BMJ Open; 2021 Feb; 11(2):e043935. PubMed ID: 33637547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unanticipated Consequences of Switching to Sugammadex: Anesthesia Provider Survey on the Hormone Contraceptive Drug Interaction.
    Dwan RL; Raymond BL; Richardson MG
    Anesth Analg; 2021 Oct; 133(4):958-966. PubMed ID: 33684087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of muscle function after deep neuromuscular block by means of diaphragm ultrasonography and adductor of pollicis acceleromyography with comparison of neostigmine vs. sugammadex as reversal drugs: study protocol for a randomized controlled trial.
    Cappellini I; Picciafuochi F; Ostento D; Danti G; De Gaudio AR; Adembri C
    Trials; 2018 Feb; 19(1):135. PubMed ID: 29467022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of rocuronium induced neuromuscular block with sugammadex or neostigmine: a large observational study.
    Della Rocca G; Pompei L; Pagan DE Paganis C; Tesoro S; Mendola C; Boninsegni P; Tempia A; Manstretta S; Zamidei L; Gratarola A; Murabito P; Fuggiano L; DI Marco P
    Acta Anaesthesiol Scand; 2013 Oct; 57(9):1138-45. PubMed ID: 23849107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neostigmine but not sugammadex impairs upper airway dilator muscle activity and breathing.
    Eikermann M; Zaremba S; Malhotra A; Jordan AS; Rosow C; Chamberlin NL
    Br J Anaesth; 2008 Sep; 101(3):344-9. PubMed ID: 18559352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.